Quiescent cells: A natural way to resist chemotherapy

作者: S.A. Menchón , C.A. Condat

DOI: 10.1016/J.PHYSA.2011.05.009

关键词:

摘要: Abstract Most chemotherapeutic treatments use drugs that target proliferating cancer cells. Therefore, they do not affect quiescent cells which are naturally resistant. Surviving can reactivate their cell cycles in the intervals between doses, becoming proliferative again and thus restarting tumor growth. In this work, we present a mathematical model to study impact of on chemotherapy effectiveness. Our simulations show that, although growth is delayed after beginning each dose, resistance enough it due accelerated repopulation, eventually causing therapy failure even absence acquired resistance.

参考文章(52)
Paul G. Tardi, Nancy Dos Santos, Troy O. Harasym, Sharon A. Johnstone, Natalia Zisman, Alan W. Tsang, David G. Bermudes, Lawrence D. Mayer, Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo. Molecular Cancer Therapeutics. ,vol. 8, pp. 2266- 2275 ,(2009) , 10.1158/1535-7163.MCT-09-0243
Steven A. Rosenberg, Vincent T. DeVita, Theodore S. Lawrence, DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology ,(2011)
K. N. Sugahara, T. Teesalu, P. P. Karmali, V. R. Kotamraju, L. Agemy, D. R. Greenwald, E. Ruoslahti, Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. ,vol. 328, pp. 1031- 1035 ,(2010) , 10.1126/SCIENCE.1183057
Alison J Davis, Ian F Tannock, Repopulation of tumour cells between cycles of chemotherapy: a neglected factor. Lancet Oncology. ,vol. 1, pp. 86- 93 ,(2000) , 10.1016/S1470-2045(00)00019-X
Vivek Anantharaman, L Aravind, Novel eukaryotic enzymes modifying cell-surface biopolymers Biology Direct. ,vol. 5, pp. 1- 8 ,(2010) , 10.1186/1745-6150-5-1
Kristin R. Swanson, Carly Bridge, J.D. Murray, Ellsworth C. Alvord, Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. Journal of the Neurological Sciences. ,vol. 216, pp. 1- 10 ,(2003) , 10.1016/J.JNS.2003.06.001
L.G. de Pillis, W. Gu, A.E. Radunskaya, Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. Journal of Theoretical Biology. ,vol. 238, pp. 841- 862 ,(2006) , 10.1016/J.JTBI.2005.06.037
Manuel Hidalgo, Jan C. Buckner, Charles Erlichman, Marilyn S. Pollack, Joseph P. Boni, Gary Dukart, Bonnie Marshall, Lisa Speicher, Laurence Moore, Eric K. Rowinsky, A Phase I and Pharmacokinetic Study of Temsirolimus (CCI-779) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients with Advanced Cancer Clinical Cancer Research. ,vol. 12, pp. 5755- 5763 ,(2006) , 10.1158/1078-0432.CCR-06-0118
Yi Jiang, Jelena Pjesivac-Grbovic, Charles Cantrell, James P. Freyer, A Multiscale Model for Avascular Tumor Growth Biophysical Journal. ,vol. 89, pp. 3884- 3894 ,(2005) , 10.1529/BIOPHYSJ.105.060640
Willem Vaalburg, Harald J. Hoekstra, Annemieke C. Kole, Willemina M. Molenaar, Boudewijn E.C. Plaat, FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy. The Journal of Nuclear Medicine. ,vol. 40, pp. 381- 386 ,(1999)